Wetherby Asset Management Inc Charles River Laboratories International, Inc. Transaction History

Wetherby Asset Management Inc

$2.19 Billion
Q2 2025

A detailed history of Wetherby Asset Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wetherby Asset Management Inc holds 1,511 shares of CRL stock, worth $252,382. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,511

Previous 1,603 5.74%

Holding current value

$252,382

Previous $295,000 22.37%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$99.75 - $151.89 $9,177 - $13,973	-92 Reduced 5.74%	1,511 $229,000
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $12,143 - $15,006	-68 Reduced 4.07%	1,603 $295,000
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $6,766 - $8,830	-36 Reduced 2.11%	1,671 $329,000
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $14,856 - $19,960	-73 Reduced 4.1%	1,707 $462,000
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $1,645 - $2,388	10 Added 0.56%	1,780 $420,000
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $27,027 - $30,247	-139 Reduced 7.28%	1,770 $346,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $1,469 - $1,682	8 Added 0.42%	1,909 $401,000
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $4,989 - $6,757	-26 Reduced 1.35%	1,901 $383,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $4,533 - $5,751	23 Added 1.21%	1,927 $419,000
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $8,392 - $11,524	-46 Reduced 2.36%	1,904 $375,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $32,048 - $47,476	157 Added 8.76%	1,950 $417,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $11,242 - $15,932	44 Added 2.52%	1,793 $509,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $66,059 - $84,351	-188 Reduced 9.71%	1,749 $659,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $4,844 - $5,957	-13 Reduced 0.67%	1,937 $799,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $573,631 - $724,717	1,950 New	1,950 $721,000
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $483,111 - $579,493	-1,935 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$222.0 - $252.62 $5,550 - $6,315	25 Added 1.31%	1,935 $483,000
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $335,319 - $432,519	1,910 New	1,910 $433,000

Others Institutions Holding CRL

# of Institutions

616

Shares Held

52.7M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.5B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Charles River Laboratories International, Inc. Transaction History